ArticleCurrent medicinal chemistry2026

Discovery of Small Molecule Inhibitors Targeting CTNNB1 (β-catenin) for Endometrial cancer: Employing 3D QSAR, Drug-Likeness Assessment, ADMET Predictions, Molecular Docking and Simulation.

Israr Fatima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.